Articles Posted in Recalls

Parents of new babies in many parts of the country had a hard time finding infant formulas such as Similac and Enfamil.  The supply chain problems currently hampering the U.S. economy have created a very acute shortage of infant formula, resulting in empty shelves and understandably stressed and concerned parents.  There are concerns in 2024 about the infant formula supply chain and the fact that just a few companies control the market.

FORMULA SHORTAGE UPDATES

April 18, 2025: Despite a highly publicized promise from Health and Human Services Secretary Robert F. Kennedy Jr. to make infant formula safer through his newly launched “Operation Stork Speed,” the FDA has quietly dismantled a key research team devoted to that exact mission. Earlier this month, roughly 15 out of 20 scientists in the FDA’s Division of Food Processing Science and Technology—including those specifically working to reduce contamination in powdered formula—were told their positions were being eliminated.

Note: At the bottom of this 13-year-old post is new 2024 information on the new Chantix cancer class action lawsuit. We are not handling these claims or any claims involving Chantix.

Chantix Lawsuits

Chantix has been a controversial drug from day one and consumer advocates have long been pushing for its removal from the very beginning. It has been associated with many side effects, including increased risk for aggressive and suicidal behavior, diabetes, and a host of other ailments.   The warning label was eventually changed on the risk of suicide and suicidal ideations (and later changed back with an acknowledgment of psychiatric events that have occurred with people on Chantix).

Some consumer complaints have been proven, some have been disproven, and the jury is still out on others. But now the data is showing something else new that Pfizer will also probably ignore: Chantix increases the risk of heart attack or stroke.

• December 2022 Update: New lawsuit alleges that Chantix is effectively worthless because it was contaminated with nitrosamines, a likely carcinogenic.

Continue reading

The Food and Drug Administration (FDA) has issued a public notice to health care providers and patients that certain hemodialysis machines manufactured by Fresenius Medical Care may be exposing users to toxic chemicals. Exposure to these toxins could cause patients to suffer neurologic conditions and hormone disorders. Our firm is not evaluating potential lawsuits against Fresenius by individuals who were harmed by this issue.

This post is part 2012 and part 2024 as we look back on this litigation, how it played out, and how much the Fresenius dialysis settlements were.

Fresenius Dialysis Machines Exposes Users to Toxic Chemicals

Reglan is a pharmaceutical drug used to combat heartburn and slow gastric emptying in diabetes patients. The question is whether tardive dyskinesia (also known as TD), a neurological disorder with symptoms including repeated involuntary movements, is connected to Reglan use.

Below is a question and answer for about the Reglan lawsuits. This will read a little odd in places because much of it was written thirteen years ago. But it has 2022 additions as well, including a discussion of the possibility of a new Reglan lawsuit over the undisclosed stroke risk.

What Is Reglan?

Knee replacement and knee implant lawsuits allege that devices loosened or did not last as long as they should.  Zimmer faced over 15,000 Biomet lawsuits over its NexGen implant. DePuy Synthes Attune Knee implant lawsuits were also a big thing.  Now Exactech recall lawsuits will be getting filed in massive numbers in 2022 after a big recall.

There have been a lot of questions about hip and knee replacements in recent years. DePuy, Exactech, Stryker, and Zimmer have had – to put it mildly – concerns raised about their products. These companies would argue that the problems are mostly with patients who are having bad outcomes and blaming the insurance companies.

Continue reading